Enantioselective separation of rivastigmine by capillary electrophoresis with cyclodextrines.

Different beta-cyclodextrines (beta-cyclodextrin, heptakis (2,3,6-tri-O-methyl)-beta-cyclodextrin, hydroxypropyl-beta-cyclodextrin, and sulfated beta-cyclodextrin) were investigated as additives for the enantioselective separation of the R-form from rivastigmine ((S)-N-ethyl-3-[(1-dimethylamino) ethyl]-N-methyl-phenyl carbamate), contained as impurity in this drug, which is used for the treatment of Alzheimer's disease. Electrophoresis was performed in an acidic background electrolyte (triethanolammonium phosphate, 75 mM, pH 2.5) with various concentrations of the additives. The electrophoretic mobilities measured are typical functions of the additive concentrations, with complex constants (obtained by fitting the appropriate binding curve on the data) ranging between about 180 and 770 M(-1). Best separation was obtained with 7.5 mM beta-cyclodextrin, with the R-enantiomer as impurity migrating before the main S-compound. Intra- and interday reproducibility (n = 6 and 18, respectively) of migration time and peak area was in the low percentage range, linearity of the calibration line for the quantitation of the impurity in the range between 2.3 and 50 microg/ml, expressed by the linear correlation coefficient, was 0.9998. The limits of detection and quantitation, respectively, were 0.7 and 2.3 microg/ml, corresponding to 0.05 and 0.15%, m/m of the R- relative to the S-compound. Analysis can be carried out at 18 degrees C in less than 19 min.

On-line affinity selection of histidine-containing peptides using a polymeric monolithic support for capillary electrophoresis.

An on-line affinity selection method using a polymeric monolithic support is proposed for the retention of histidine-containing peptides and their subsequent separation by capillary zone electrophoresis (CZE). Monolithic capillary columns were prepared in fused-silica capillaries of 150 mum inner diameter (ID) by ionizing radiation-initiated in situ polymerization and cross-linking of diethylene glycol dimethacrylate and glycidyl methacrylate, and chemically modified with iminodiacetic acid (IDA) and copper ion. Monolithic microextractors were coupled on-line near the inlet of the separation capillary (fused-silica capillary, 75 mum ID x 28 cm from the microextractor to the detector). Model peptide mixtures of histidine-containing and histidine-noncontaining peptides were assessed. Peptides were released from the sorbent by a 5 mM imidazole solution and then separated by CZE with ultraviolet detection. Relative standard deviation values for migration times and corrected peak areas were found to be lower than 5.8 and 10.5%, respectively. IDA-Cu(II) ion modified monolithic microextractors showed a chromatographic behavior and could be reused at least 25 times. The use of monolithic supports proved to be an advantageous alternative to packed particles for the preparation of microextractors.

Relation between retention factors of immunosuppressive drugs in microemulsion electrokinetic chromatography with biosurfactants and octanol-water partition coefficients.

Retention (capacity) factors (k' values) of immunosuppressive drugs were determined in microemulsion electrokinetic chromatography (MEEKC) systems as a tool for the indirect estimation of partition coefficients (POW) between 1-octanol and water. The microemulsions were based on phosphatidylcholine (PC) and bile acids (BAs) as biosurfactants and isopropyl myristate (IPM) as oil. Immunosuppressants were azathioprine (AZA), mycophenolate mofetil (MMF), tacrolimus (FK506) and cyclosporine A (CyA). Capacity factors of the analytes were determined from electrophoretic mobilities using an aqueous phosphate buffer (20 mM; pH 7.5) for all the systems. Retention was compared with that in the most commonly used microemulsion based on sodium dodecyl sulphate (SDS). logPOW versus logk' calibration lines were constructed using reference compounds with known POW. In addition, data of logPOW of the immunosuppressants were determined by partitioning between octanol and water, and were calculated by the aid of computer program. A different sequence of logPOW for two analytes was found in the biosurfactant-based systems compared with the SDS-containing one. Excellent agreement was observed between the logPOW values derived from the microemulsions containing deoxycholate compared with the data determined by partitioning between octanol and water. It was concluded that the retention factors in the systems with biosurfactants are good estimators for the partitioning in biological systems.

Comparison of the retention characteristics of different pseudostationary phases for microemulsion and micellar electrokinetic chromatography of betamethasone and derivatives.

Five electrokinetic chromatography systems were compared concerning retention behavior and lipophilicity. Comparison was based on capacity (retention) factors of some steroidal drugs, and on log P(OW) values derived by the aid of reference substances. In all systems the aqueous buffer consisted of phosphate (20 mM, pH 7.5). Two systems had micelles, three systems microdroplets as negatively charged pseudostationary phases. The micelles were formed by sodium dodecyl sulfate (SDS) and sodium cholate, respectively. One microemulsion consisted (as usual) from octane as oil, butanol as cosurfactant and SDS as charged tenside. Two microemulsions were made from biosurfactants (phosphatidylcholine, isopropylmyristate) to better simulate biopartitioning of the drugs. Even for noncharged analytes a change in migration sequence and thus in log P(OW) was observed for the systems consisting of the biosurfactants, compared to the others. For the former systems, log P(OW) derived from the capacity factors agree for all analytes with those obtained from calculation by computer software based on the structure of the drugs, and with experimental data directly obtained from octanol/water partitioning.

Optimización del análisis de ácidos biliares séricos por método enzimático fluorométrico / Improvement of an enzymatic fluorometric assay for serum bile acids

Con el objeto de optimizar la determinación fluorométrica de los ácidos biliares séricos (ABS) en cuanto a selectividad y sensibilidad, se desarrolló una metodología de preparación de muestra y preconcentración utilizando columnas de extracción en fase sólida (SPE-C18). Previa desproteinización del suero con acetonitrilo frío, la fase orgánica evaporada y reconstituida con acetonitrilo: agua (3:70), se aplicó a una columna SPE-C18 y los ABS fueron eluidos con metanol. En el extractivo metanólico, evaporado a sequedad y reconstituido con metanol se dosaron los ABS por método enzimático fluorométrico empleando 3Ó-hidroxiesteroide deshidrogenasa, ß-NAD, diaforasa y resazurina. En la validación de la preparación de muestra se utilizó [24-14C] ácido glicocólico. La recuperación fue del 89,0 ñ 1,3 por ciento (SD), con DSR de 1,4 para n=9 (3 días). Se determinaron los ABS en sujetos controles, resultando un valor medio de 2,61 ñ 0,39 µM (SEM) (n=27). La metodología propuesta combina las siguientes ventajas: aumento de la selectividad del método enzimático, eliminación de interferencias y preconcentración de los ABS liberados, previamente, de la unión a proteínas plasmáticas

Efecto del ácido quenodesoxicólico sobre la composición de los ácidos biliares en bilis de hámster / Effect of chenodeoxycholic acid on the composition of biliary bile acids in hamster

Se investiga la modificación en la composición de los ácidos biliares de hámster por administración de altas dosis de ácido quenodeoxicólico (CDCA). Treinta hámster dorados, machos, fueron divididos en 5 grupos, uno de control y los otros cuatro recibieron 0,5g y 1g de CDCA por 100g de dieta estándar, durante 30 y 60 días. Luego de anestesia con éter se extrajo la vesícula y se aspiró la bilis inmediatamente. Los ácidos biliares se determinaron por cromatografía líquida de alta resolución (HPLC). Los conjugados del CDCA y del ácido litocólico (LCA) mostraron aumentos no relacionados con la dosis o el tiempo de tratamiento. También se observó un aumento moderado de los ceto derivados del CDCA, especialmente, uno de los glico conjugados. La relación cólico/queno disminuyó significativamente. Los ácidos taurolitocólico (TLCA) y glicolitocólico (GLCA) aumentaron significativamente en todos los grupos tratados. La relación glico/tauro conjugados de 1,17 en los controles aumentó a aproximadamente 3,0 en los tratados. Con respecto a la relación G/T del LCA de 0,38 en el grupo control aumentó a un valor cercano a 2,0 en los tratados.